Walleye Trading
EBS icon

Walleye Trading’s Emergent Biosolutions EBS Stock Holding History

Walleye Trading’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,500
Closed -$35.1K – 4476
2025
Q2 		$35.1K Buy
+5,500
New +$31.5K ﹤0.01% 3890
2023
Q4 		– Sell
-3,400
Closed -$11.6K – 5161
2023
Q3 		$11.6K Sell
3,400
-15,100
-82% -$83.7K ﹤0.01% 4506
2023
Q2 		$136K Buy
+18,500
New +$172K ﹤0.01% 3628
2022
Q4 		– Sell
-4,800
Closed -$101K – 5066
2022
Q3 		$101K Buy
+4,800
New +$134K ﹤0.01% 4046
2016
Q3 		– Sell
-29,900
Closed -$841K – 4969
2016
Q2 		$841K Buy
+29,900
New +$1.17M 0.01% 1755

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Walleye Trading's EBS Position: Q4 2023 in Review

Walleye Trading sold out of Emergent Biosolutions (EBS) in Q4 2023, closing a stake of 1,620 shares — an estimated $5.51K sold.

Walleye Trading first reported a position in EBS in Q2 2015 and held it in 9 quarters. The position peaked at $692K in Q2 2016. 134 funds tracked by Wall St. Rank hold EBS as of Q4 2023.

  • Walleye Trading reported no remaining Emergent Biosolutions position as of Q4 2023 after selling out during the quarter.
  • Walleye Trading sold 1,620 Emergent Biosolutions shares in Q4 2023, an estimated $5.51K.
  • Walleye Trading first reported a position in Emergent Biosolutions in Q2 2015 and held it in 9 quarters.
  • Walleye Trading's Emergent Biosolutions position peaked at $692K in Q2 2016.
  • 134 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.